2017 | 08 | 29

Vironova joined innovators and investors forging the future of Swedish life science entrepreneurship

As a Gold sponsor of the Swedish American Life Science Summit in Stockholm, Vironova was in good company last week.

While Vironova invests its innovation-muscle and expertise in the future of image analysis for biopharma, others are looking to invest capital to boost Swedish Life Science entrepreneurship and innovation. Last week we met up to build strategic and collaborative relationships that will enhance Life Science business.

The annual, by-invitation-only SALSS conference brings together some of the most renowned Life Science executives, scientists, entrepreneurs and investors over three days in Stockholm, this year finishing up at the premises of Nasdaq Stockholm. The conference includes panel discussions, insights from keynote speakers and presentations from distinguished life science executives and investors throughout the world.

Many new relationships were forged and Vironova is again honoured to be recognized as a significant and innovative player in the Life science sector.


News and events

Read about the latest news and events at Vironova.

  • All news
  • Inside Vironova
  • Open positions
  • Events and publications
VIEW MORE
VIEW MORE
VIEW MORE
VIEW MORE

On demand webinar

  • Title: Unmatched Viral Particle Analysis in Vaccine and Gene Therapy Development
  • Speaker: Josefina Nilsson, head of EM services & Martin Ryner, Strategic development manager
  • Watch webinar

Upcoming events 2017

Cell & Gene Therapy Europe 2017
6-7 December, Amsterdam
Booth 24

Vironova on MyNewsDesk

Follow us on MyNewsDesk and get the latest info on investor relations, events and company news.
Click here to get to our MyNewsDesk-page.

Press contact
For press enquiries, please contact
info@vironova.com

IR contact
Mohammed Homman
ceo@vironova.com